Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y F Hui

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Xianggang Hu Li Za Zhi. the Hong Kong Nursing Journal|May 1, 1975
Responsibilities towards our profession and the communityY F Hui
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 15, 1997
Gemcitabine: a cytidine analogue active against solid tumorsY F Hui, J Reitz
Cancer Practice|October 28, 1997
Dolasetron. A new 5-hydroxytryptamine3 receptor antagonistY F Hui, R J Ignoffo
Cancer Practice|March 1, 1997
Docetaxel in anthracycline-resistant metastatic breast cancerY F Hui, R J Ignoffo
Pharmacotherapy|October 18, 2000
Palmar-plantar erythrodysesthesia syndrome associated with liposomal daunorubicinY F Hui, J E Cortes
The Annals of Pharmacotherapy|June 22, 2000
Chest and back pain associated with a six-hour infusion of liposomal daunorubicinY F Hui, J E Cortes
Cancer Practice|February 14, 1998
Angiogenesis inhibitors. A promising role in cancer therapyY F Hui, R J Ignoffo
Blood|November 15, 1996
Identification of mutations in seven Chinese patients with X-linked chronic granulomatous diseaseY F Hui, S Y Chan, Y L Lau
Biochemical Pharmacology|July 19, 1994
Intestinal clearance of H2-antagonistsY F Hui, J Kolars, Z Hu, et al.
Endocrinology|October 1, 1975
Renal medullary adenylate cyclase in rats with hypothalamic diabetes insipidusT P Dousa, Y F Hui, L D Barnes
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Xianggang Hu Li Za Zhi. the Hong Kong Nursing Journal|May 1, 1975
Responsibilities towards our profession and the communityY F Hui
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 15, 1997
Gemcitabine: a cytidine analogue active against solid tumorsY F Hui, J Reitz
Cancer Practice|October 28, 1997
Dolasetron. A new 5-hydroxytryptamine3 receptor antagonistY F Hui, R J Ignoffo
Cancer Practice|March 1, 1997
Docetaxel in anthracycline-resistant metastatic breast cancerY F Hui, R J Ignoffo
Pharmacotherapy|October 18, 2000
Palmar-plantar erythrodysesthesia syndrome associated with liposomal daunorubicinY F Hui, J E Cortes
The Annals of Pharmacotherapy|June 22, 2000
Chest and back pain associated with a six-hour infusion of liposomal daunorubicinY F Hui, J E Cortes
Cancer Practice|February 14, 1998
Angiogenesis inhibitors. A promising role in cancer therapyY F Hui, R J Ignoffo
Blood|November 15, 1996
Identification of mutations in seven Chinese patients with X-linked chronic granulomatous diseaseY F Hui, S Y Chan, Y L Lau
Biochemical Pharmacology|July 19, 1994
Intestinal clearance of H2-antagonistsY F Hui, J Kolars, Z Hu, et al.
Endocrinology|October 1, 1975
Renal medullary adenylate cyclase in rats with hypothalamic diabetes insipidusT P Dousa, Y F Hui, L D Barnes
Pageof 2